Resistant Hypertension in Chronic Kidney Disease
Herausgegeben:Covic, Adrian; Kanbay, Mehmet; Lerma, Edgar V.
Resistant Hypertension in Chronic Kidney Disease
Herausgegeben:Covic, Adrian; Kanbay, Mehmet; Lerma, Edgar V.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This comprehensive volume provides a detailed review on the general work up of chronic kidney disease-associated resistant hypertension. This title is separated into four parts; the first of which provides definitions, epidemiology, characteristics, risk stratification and outcomes of resistant and apparent treatment resistant hypertension. The next two sections explore pathophysiology and diagnosis, treatment in the light of new guidelines, as well as procedures and devices for neural modulation. Part four discusses public health approaches to resistant hypertension, educational programs, and…mehr
Andere Kunden interessierten sich auch für
![Resistant Hypertension]( "Resistant Hypertension")
Massimo SalvettiResistant Hypertension37,99 €![Pulse Waves]( "Pulse Waves")
Paolo SalviPulse Waves74,99 €![Interventional Therapies for Secondary and Essential Hypertension]( "Interventional Therapies for Secondary and Essential Hypertension")
Interventional Therapies for Secondary and Essential Hypertension88,99 €![Hypertension and Metabolic Cardiovascular Risk Factors]( "Hypertension and Metabolic Cardiovascular Risk Factors")
Arrigo F. G. CiceroHypertension and Metabolic Cardiovascular Risk Factors37,99 €![Hypertension and Organ Damage]( "Hypertension and Organ Damage")
Giuliano TocciHypertension and Organ Damage37,99 €![Hypertension and Comorbidities]( "Hypertension and Comorbidities")
Agostino VirdisHypertension and Comorbidities37,99 €![Heart Failure Management: The Neural Pathways]( "Heart Failure Management: The Neural Pathways")
Heart Failure Management: The Neural Pathways74,99 €-
-
-
This comprehensive volume provides a detailed review on the general work up of chronic kidney disease-associated resistant hypertension. This title is separated into four parts; the first of which provides definitions, epidemiology, characteristics, risk stratification and outcomes of resistant and apparent treatment resistant hypertension. The next two sections explore pathophysiology and diagnosis, treatment in the light of new guidelines, as well as procedures and devices for neural modulation. Part four discusses public health approaches to resistant hypertension, educational programs, and resistant hypertension for general practitioners. Resistant Hypertension in CKD brings up-to-date information to nephrologists, internists, cardiologists and a wide array of other clinicians and health professionals taking care of chronic kidney disease patients.
Produktdetails
- Produktdetails
- Verlag: Springer / Springer International Publishing / Springer, Berlin
- Artikelnr. des Verlages: 978-3-319-56825-6
- 1st ed. 2017
- Seitenzahl: 384
- Erscheinungstermin: 22. November 2017
- Englisch
- Abmessung: 241mm x 160mm x 27mm
- Gewicht: 727g
- ISBN-13: 9783319568256
- ISBN-10: 3319568256
- Artikelnr.: 47757438
- Verlag: Springer / Springer International Publishing / Springer, Berlin
- Artikelnr. des Verlages: 978-3-319-56825-6
- 1st ed. 2017
- Seitenzahl: 384
- Erscheinungstermin: 22. November 2017
- Englisch
- Abmessung: 241mm x 160mm x 27mm
- Gewicht: 727g
- ISBN-13: 9783319568256
- ISBN-10: 3319568256
- Artikelnr.: 47757438
Adrian Covic, MD, PhD, FERA, FESC, FRCP (London) Professor Internal Medicine & Nephrology University of Medicine,Grigore T. Popa, Iasi, Romania Mehmet Kanbay, MD Professor of Medicine and Nephrology Department of Medicine Division of Nephrology University School of Medicine Istanbul, Turkey Edgar V. Lerma, MD Clinical Professor of Medicine Section of Nephrology University of Illinois at Chicago College of Medicine Associates in Nephrology, SC Chicago, Illinois
Chapter 1. Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension.- Chapter 2. Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data.- Chapter 3. Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?.- Chapter 4. The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease.- Chapter 5. Resistant Hypertension and Outcomes in Patients With and Without Chronic Kidney Disease.- Chapter 6. Risk Stratification of Resistant Hypertension in Chronic Kidney Disease.- Chapter 7. Pathophysiological Insights in Resistant Hypertension.- Chapter 8. Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease.- Chapter 9. Secondary Causes: Work-up and Its Specificities in CKD, Which is the Most Common Identifiable Cause of Hypertension. I. Influence of Arterial Stiffening.- Chapter 10. Secondary Causes: Work-up and Its Specificities in CKD, Which Is the Most Common Identifiable Cause of Hypertension. II: Influence of Autonomic Dysfunction.- Chapter 11. Secondary Causes: Influence of Volume Overload, Especially in CKD Patients: Excess Sodium Intake, Salt Retention in CKD.- Chapter 12. Resistant hypertension in elderly people with chronic kidney disease.- Chapter 13. Obstructive Sleep Apnea and Resistant Hypertension.- Chapter 14. Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease.- Chapter 15. Public Health Efforts for Earlier Resistance Hypertension: Diagnosis, Reduction of Salt Content in Food, Promotion of the Use of Polypills to Facilitate Adherence, and Reimbursement Policies.- Chapter 16. Treatment of Resistant Hypertension in the Light of New Guidelines: Drug Adherence.- Chapter 17. Treatment of Resistant Hypertension in the Light of New Guidelines: Pharmacological Approaches Using Multiple Drugs.- Chapter 18.Devices for Neural Modulation (Renal Denervation, Barostimulation).- Chapter 19. The Effect of CPAP Therapy on Resistant Hypertension in Obstructive Sleep Apnea Syndrome Patients with Chronic Kidney Disease.- Chapter 20. Teaching Programs.- Chapter 21. Resistant Hypertension and the General Practitioner (Monitoring, Treatment).
Chapter 1. Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension.- Chapter 2. Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data.- Chapter 3. Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?.- Chapter 4. The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease.- Chapter 5. Resistant Hypertension and Outcomes in Patients With and Without Chronic Kidney Disease.- Chapter 6. Risk Stratification of Resistant Hypertension in Chronic Kidney Disease.- Chapter 7. Pathophysiological Insights in Resistant Hypertension.- Chapter 8. Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease.- Chapter 9. Secondary Causes: Work-up and Its Specificities in CKD, Which is the Most Common Identifiable Cause of Hypertension. I. Influence of Arterial Stiffening.- Chapter 10. Secondary Causes: Work-up and Its Specificities in CKD, Which Is the Most Common Identifiable Cause of Hypertension. II: Influence of Autonomic Dysfunction.- Chapter 11. Secondary Causes: Influence of Volume Overload, Especially in CKD Patients: Excess Sodium Intake, Salt Retention in CKD.- Chapter 12. Resistant hypertension in elderly people with chronic kidney disease.- Chapter 13. Obstructive Sleep Apnea and Resistant Hypertension.- Chapter 14. Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease.- Chapter 15. Public Health Efforts for Earlier Resistance Hypertension: Diagnosis, Reduction of Salt Content in Food, Promotion of the Use of Polypills to Facilitate Adherence, and Reimbursement Policies.- Chapter 16. Treatment of Resistant Hypertension in the Light of New Guidelines: Drug Adherence.- Chapter 17. Treatment of Resistant Hypertension in the Light of New Guidelines: Pharmacological Approaches Using Multiple Drugs.- Chapter 18.Devices for Neural Modulation (Renal Denervation, Barostimulation).- Chapter 19. The Effect of CPAP Therapy on Resistant Hypertension in Obstructive Sleep Apnea Syndrome Patients with Chronic Kidney Disease.- Chapter 20. Teaching Programs.- Chapter 21. Resistant Hypertension and the General Practitioner (Monitoring, Treatment).
Chapter 1. Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension.- Chapter 2. Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data.- Chapter 3. Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?.- Chapter 4. The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease.- Chapter 5. Resistant Hypertension and Outcomes in Patients With and Without Chronic Kidney Disease.- Chapter 6. Risk Stratification of Resistant Hypertension in Chronic Kidney Disease.- Chapter 7. Pathophysiological Insights in Resistant Hypertension.- Chapter 8. Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease.- Chapter 9. Secondary Causes: Work-up and Its Specificities in CKD, Which is the Most Common Identifiable Cause of Hypertension. I. Influence of Arterial Stiffening.- Chapter 10. Secondary Causes: Work-up and Its Specificities in CKD, Which Is the Most Common Identifiable Cause of Hypertension. II: Influence of Autonomic Dysfunction.- Chapter 11. Secondary Causes: Influence of Volume Overload, Especially in CKD Patients: Excess Sodium Intake, Salt Retention in CKD.- Chapter 12. Resistant hypertension in elderly people with chronic kidney disease.- Chapter 13. Obstructive Sleep Apnea and Resistant Hypertension.- Chapter 14. Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease.- Chapter 15. Public Health Efforts for Earlier Resistance Hypertension: Diagnosis, Reduction of Salt Content in Food, Promotion of the Use of Polypills to Facilitate Adherence, and Reimbursement Policies.- Chapter 16. Treatment of Resistant Hypertension in the Light of New Guidelines: Drug Adherence.- Chapter 17. Treatment of Resistant Hypertension in the Light of New Guidelines: Pharmacological Approaches Using Multiple Drugs.- Chapter 18.Devices for Neural Modulation (Renal Denervation, Barostimulation).- Chapter 19. The Effect of CPAP Therapy on Resistant Hypertension in Obstructive Sleep Apnea Syndrome Patients with Chronic Kidney Disease.- Chapter 20. Teaching Programs.- Chapter 21. Resistant Hypertension and the General Practitioner (Monitoring, Treatment).
Chapter 1. Definitions of Resistant Hypertension and Epidemiology of Resistant Hypertension.- Chapter 2. Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data.- Chapter 3. Apparent Treatment-Resistant Hypertension and Chronic Kidney Disease: Another Cardiovascular-Renal Syndrome?.- Chapter 4. The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant Hypertension Associated with Chronic Kidney Disease.- Chapter 5. Resistant Hypertension and Outcomes in Patients With and Without Chronic Kidney Disease.- Chapter 6. Risk Stratification of Resistant Hypertension in Chronic Kidney Disease.- Chapter 7. Pathophysiological Insights in Resistant Hypertension.- Chapter 8. Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease.- Chapter 9. Secondary Causes: Work-up and Its Specificities in CKD, Which is the Most Common Identifiable Cause of Hypertension. I. Influence of Arterial Stiffening.- Chapter 10. Secondary Causes: Work-up and Its Specificities in CKD, Which Is the Most Common Identifiable Cause of Hypertension. II: Influence of Autonomic Dysfunction.- Chapter 11. Secondary Causes: Influence of Volume Overload, Especially in CKD Patients: Excess Sodium Intake, Salt Retention in CKD.- Chapter 12. Resistant hypertension in elderly people with chronic kidney disease.- Chapter 13. Obstructive Sleep Apnea and Resistant Hypertension.- Chapter 14. Interference with Pharmacological Agents to Resistant Hypertension in Chronic Kidney Disease.- Chapter 15. Public Health Efforts for Earlier Resistance Hypertension: Diagnosis, Reduction of Salt Content in Food, Promotion of the Use of Polypills to Facilitate Adherence, and Reimbursement Policies.- Chapter 16. Treatment of Resistant Hypertension in the Light of New Guidelines: Drug Adherence.- Chapter 17. Treatment of Resistant Hypertension in the Light of New Guidelines: Pharmacological Approaches Using Multiple Drugs.- Chapter 18.Devices for Neural Modulation (Renal Denervation, Barostimulation).- Chapter 19. The Effect of CPAP Therapy on Resistant Hypertension in Obstructive Sleep Apnea Syndrome Patients with Chronic Kidney Disease.- Chapter 20. Teaching Programs.- Chapter 21. Resistant Hypertension and the General Practitioner (Monitoring, Treatment).